Literature DB >> 3426396

Orf virus replication in bovine testis cells: kinetics of viral DNA, polypeptide, and infectious virus production and analysis of virion polypeptides.

T C Balassu1, A J Robinson.   

Abstract

The replication of orf virus in bovine testis cells was analysed in one-step growth experiments. Newly replicated viral DNA was detected 4 to 6 hours post-infection (p.i.), accumulated rapidly between 8 and 16 hours p.i. and reached a plateau between 25 and 30 hours p.i. Most virus-induced polypeptides were first detected in a two hour period beginning 10 hours p.i., reached a peak rate of synthesis between 14 and 16 hours p.i., and continued at that rate for at least 10 hours. Host polypeptide synthesis declined to very low levels by 20 hours p.i. From these results, the transition between early and late events appears to occur between 8 and 10 hours p.i. Infectious virus was first detected between 16 and 18 hours p.i. and continued to be produced at a steady rate till 40 hours p.i. Up to 35 polypeptides were detected in SDS-polyacrylamide gels of purified orf virions disrupted in SDS/2-ME. Virions treated with NP40/2-ME were separable into soluble and insoluble components by centrifugation. Some 13 polypeptides were found in the soluble fraction and a polypeptide of molecular weight 38,500 believed to be the basic subunit of the virion surface tubule structure. Little difference was found between polypeptide profiles of five independently isolated NZ orf virus strains.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426396     DOI: 10.1007/BF01314426

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  Studies on the structural proteins of vaccinia virus. II. Kinetics of the synthesis of individual groups of structural proteins.

Authors:  J A Holowczak; W K Joklik
Journal:  Virology       Date:  1967-12       Impact factor: 3.616

2.  Biogenesis of vaccinia: isolation and characterization of a surface component that elicits antibody suppressing infectivity and cell-cell fusion.

Authors:  W Stern; S Dales
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

3.  Replication of vaccinia DNA in mouse L cells. I. In vivo DNA synthesis.

Authors:  M Esteban; J A Holowczak
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Heterogeneity of contagious ecthyma virus isolates.

Authors:  B M Buddle; R W Dellers; G G Schurig
Journal:  Am J Vet Res       Date:  1984-01       Impact factor: 1.156

6.  The genome of orf virus: restriction endonuclease analysis of viral DNA isolated from lesions of orf in sheep.

Authors:  A J Robinson; G Ellis; T Balassu
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Vaccinia virus polypeptide synthesis: sequential appearance and stability of pre- and post-replicative polypeptides.

Authors:  T H Pennington
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

8.  Controlled degradation of vaccinia virions in vitro: an electron microscopic study.

Authors:  K B Easterbrook
Journal:  J Ultrastruct Res       Date:  1966-03

9.  Growth kinetics of Yaba tumor poxvirus after in vitro adaptation to cercopithecus kidney cells.

Authors:  D S Yohn; F R Marmol; R G Olsen
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

10.  The rate of formation of vaccinia deoxyribonucleic acid and vaccinia virus.

Authors:  N P SALZMAN
Journal:  Virology       Date:  1960-01       Impact factor: 3.616

View more
  8 in total

1.  ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeutic.

Authors:  Julia L Rintoul; Chantal G Lemay; Lee-Hwa Tai; Marianne M Stanford; Theresa J Falls; Christiano T de Souza; Byram W Bridle; Manijeh Daneshmand; Pamela S Ohashi; Yonghong Wan; Brian D Lichty; Andrew A Mercer; Rebecca C Auer; Harold L Atkins; John C Bell
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

2.  Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.

Authors:  Da-Yuan Chen; Jacqueline-Alba Fabrizio; Sarah E Wilkins; Keyur A Dave; Jeffrey J Gorman; Jonathan M Gleadle; Stephen B Fleming; Daniel J Peet; Andrew A Mercer
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  A homolog of interleukin-10 is encoded by the poxvirus orf virus.

Authors:  S B Fleming; C A McCaughan; A E Andrews; A D Nash; A A Mercer
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Sequence and transcriptional analysis of a near-terminal region of the orf virus genome.

Authors:  J T Sullivan; S B Fleming; A J Robinson; A A Mercer
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Sequence and transcriptional analysis of an orf virus gene encoding ankyrin-like repeat sequences.

Authors:  J T Sullivan; K M Fraser; S B Fleming; A J Robinson; A A Mercer
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

6.  Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus.

Authors:  D J Lyttle; K M Fraser; S B Fleming; A A Mercer; A J Robinson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Deletion of the Chemokine Binding Protein Gene from the Parapoxvirus Orf Virus Reduces Virulence and Pathogenesis in Sheep.

Authors:  Stephen B Fleming; Catherine McCaughan; Zabeen Lateef; Amy Dunn; Lyn M Wise; Nicola C Real; Andrew A Mercer
Journal:  Front Microbiol       Date:  2017-01-24       Impact factor: 5.640

8.  A parapoxviral virion protein targets the retinoblastoma protein to inhibit NF-κB signaling.

Authors:  Ponnuraj Nagendraprabhu; Sushil Khatiwada; Sabal Chaulagain; Gustavo Delhon; Daniel L Rock
Journal:  PLoS Pathog       Date:  2017-12-15       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.